ARS Pharmaceuticals, Inc.: directors' dealings · United States · SEC (Form 4) Explore the full directors' dealings record of ARS Pharmaceuticals, Inc., a listed issuer based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €904.7m. The latest transaction was disclosed on 1 July 2025 (Cession). Among the most active insiders: Lowenthal Richard E. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 1 July 2025
All Executives119 Thresholds0 Prospectus0 Other0
Declarations 119 total
▼ 10% Owner · Executives · 27 Jun 2025
370,075 shares @ US$18.46 47.3% of flow Class A Common Stock SEC:0001193805-25-000959:0
▼ 10% Owner · Executives · 27 Jun 2025
370,074 shares @ US$18.46 47.3% of flow Class A Common Stock SEC:0001193805-25-000959:1
◇ Chief Legal Officer · Executives · 20 May 2025
100,000 shares @ US$5.58 78.3% of flow Common Stock SEC:0001415889-25-014186:0
◇ Director · Executives · 20 May 2025
120,000 shares @ US$1.01 100.0% of flow Common Stock SEC:0001415889-25-014185:0
◇ Chief Financial Officer · Executives · 20 May 2025
50,000 shares @ US$1.50 44.2% of flow Common Stock SEC:0001415889-25-014184:0
◇ Director · Executives · 7 Apr 2025
22,509 shares @ US$4.85 2.8% of flow Common Stock SEC:0001415889-25-010395:0
◇ Director · Executives · 7 Apr 2025
27,493 shares @ US$4.85 3.4% of flow Common Stock SEC:0001415889-25-010395:1
▼ Director · Executives · 7 Apr 2025
50,002 shares @ US$12.301 15.7% of flow Common Stock SEC:0001415889-25-010395:2
◇ Chief Commercial Officer · Executives · 20 Mar 2025
10,000 shares @ US$1.50 29.8% of flow Common Stock SEC:0001415889-25-008796:0
◇ Director · Executives · 5 Mar 2025
400 shares @ US$4.85 0.1% of flow Common Stock SEC:0001415889-25-007438:0
◇ Director · Executives · 3 Feb 2025
9,064 shares @ US$3.15 0.8% of flow Common Stock SEC:0001415889-25-002955:0
◇ Director · Executives · 3 Feb 2025
40,936 shares @ US$4.85 5.4% of flow Common Stock SEC:0001415889-25-002955:1
▼ Director · Executives · 3 Feb 2025
50,000 shares @ US$12.3113 16.7% of flow Common Stock SEC:0001415889-25-002955:2
◇ Director · Executives · 6 Jan 2025
50,000 shares @ US$3.15 4.3% of flow Common Stock SEC:0001415889-25-001053:0
▼ Director · Executives · 6 Jan 2025
50,000 shares @ US$11.1013 15.0% of flow Common Stock SEC:0001415889-25-001053:1
▼ PRESIDENT AND CEO · Executives · 17 Dec 2024
50,000 shares @ US$11.6715 6.2% of flow Common Stock SEC:0001415889-24-029851:0
▼ CHIEF MEDICAL OFFICER · Executives · 17 Dec 2024
50,000 shares @ US$11.6715 6.2% of flow Common Stock SEC:0001415889-24-029852:0
◇ Chief Operating Officer · Executives · 11 Dec 2024
15,000 shares @ US$0.64 16.5% of flow Common Stock SEC:0001415889-24-029376:0
◇ Chief Business Officer · Executives · 12 Dec 2024
117,333 shares @ US$0.84 14.6% of flow Common Stock SEC:0001415889-24-029377:0
◇ Chief Business Officer · Executives · 10 Dec 2024
50,000 shares @ US$0.84 6.2% of flow Common Stock SEC:0001415889-24-029162:0
▼ PRESIDENT AND CEO · Executives · 10 Dec 2024
50,000 shares @ US$13.1653 6.9% of flow Common Stock SEC:0001415889-24-029011:0
▼ CHIEF MEDICAL OFFICER · Executives · 10 Dec 2024
50,000 shares @ US$13.1653 7.0% of flow Common Stock SEC:0001415889-24-029012:0
◇ CHIEF MEDICAL OFFICER · Executives · 6 Dec 2024
13,789 shares @ US$1.44 0.2% of flow Common Stock SEC:0001415889-24-028692:0
◇ PRESIDENT AND CEO · Executives · 6 Dec 2024
11,876 shares @ US$8.42 1.1% of flow Common Stock SEC:0001415889-24-028678:0
◇ Chief Business Officer · Executives · 4 Dec 2024
45,000 shares @ US$0.84 5.6% of flow Common Stock SEC:0001415889-24-028567:0
25 of 119 declarations
Load more (94 remaining)